ACUTAAS vs QMSMEDI: Stock Comparison

Acutaas Chemicals Limited vs QMS Medical Allied Services Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Acutaas Chemicals Limited shows a higher ROE, faster revenue growth and lower leverage, while QMS Medical Allied Services Ltd shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Acutaas Chemicals Limited and QMS Medical Allied Services Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ACUTAAS is more favourable on 10 of 13 scored metrics and QMSMEDI on 3These counts are context-free and are not an overall rating.

Key Differences

P/E Ratio
QMSMEDI has a lower P/E
12.43x vs 69x
P/B Ratio
QMSMEDI has a lower P/B
1.95x vs 16.12x
EPS
ACUTAAS has higher earnings per share
₹34.93 vs ₹5.24
Dividend Yield
QMSMEDI has a higher dividend yield
0.48% vs 0.04%
Revenue Growth (TTM YoY)
ACUTAAS has faster revenue growth
40.3% vs 0%
EPS Growth (TTM YoY)
ACUTAAS has faster EPS growth
105.6% vs 0%
Qtr Sales Growth
ACUTAAS has stronger quarterly sales growth
40.3% vs -0.36%
Qtr Profit Growth
ACUTAAS has stronger quarterly profit growth
111% vs -48.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricACUTAASQMSMEDI
SectorHealthcare
IndustryPharmaceuticals

Price

MetricACUTAASQMSMEDI
Live Price₹3,259.5₹110.6
Day Change-5.77%2.24%
Volume12.43 L18,570
52-Week High₹3,740₹118.7
52-Week Low₹1,125₹98.05
Distance from 52W High-12.85%-6.82%

Valuation

MetricACUTAASQMSMEDI
Market Cap₹26,810 Cr
P/E Ratio69x12.43x
P/B Ratio16.12x1.95x
EPS₹34.93₹5.24
Book Value₹201.93₹53.9
Dividend Yield0.04%0.48%

Growth

MetricACUTAASQMSMEDI
Revenue Growth (TTM YoY)40.3%0%
EPS Growth (TTM YoY)105.6%0%
Qtr Sales Growth40.3%-0.36%
Qtr Profit Growth111%-48.5%

Profitability & Leverage

MetricACUTAASQMSMEDI
ROE24%10.4%
ROCE31.6%13.2%
Net Margin26.6%0%
Operating Margin35.9%15%
Debt to Equity0.02x0.65x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricACUTAASQMSMEDI
Promoter Holding32.66%68.11%
FII Holding21.61% 2.13 pp0%
DII Holding19.56% 0.04 pp1.59%
Public Holding26.16% 2.08 pp30.3%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Acutaas Chemicals Limited and QMS Medical Allied Services Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.